
Profitability, historical returns, and peer comparisons.
According to MedTech Acquisition Corporation’s latest financial reports and current stock price. The company's current ROE is 273.71%. This represents a change of -1956.08% compared to the average of -14.75% of the last 4 quarters.
The mean historical ROE of MedTech Acquisition Corporation over the last ten years is 136.09%. The current 273.71% ROE has changed 101.13% with respect to the historical average. Over the past ten years (40 quarters), MTACU's ROE was at its highest in in the March 2023 quarter at 200.92%. The ROE was at its lowest in in the June 2026 quarter at -140.26%.
Average
136.09%
Median
122.09%
Minimum
-93.34%
Maximum
382.89%
Discovering the peaks and valleys of MedTech Acquisition Corporation ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual ROE = 382.89%
Minimum Annual Increase = -510.20%
Minimum Annual ROE = -93.34%
| Year | ROE | Change |
|---|---|---|
| 2025 | 115.85% | -9.74% |
| 2024 | 128.34% | -41.49% |
| 2023 | 219.33% | -42.72% |
| 2022 | 382.89% | -510.20% |
| 2021 | -93.34% | -247.08% |
The current ROE of MedTech Acquisition Corporation (MTACU) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
154.51%
5-year avg
150.61%
10-year avg
136.09%
MedTech Acquisition Corporation’s ROE is less than Edify Acquisition Corp. (8.50%), less than Frontier Investment Corp (12.10%), less than Altitude Acquisition Corp. (6.91%), greater than CXApp Inc. (-135.04%), less than Altimar Acquisition Corp. III (0%), greater than Noble Rock Acquisition Corporation (-0.02%), greater than AI Transportation Acquisition Corp. (-0.12%), greater than DigiAsia Corp. (-0.18%),
| Company | ROE | Market cap |
|---|---|---|
| 8.50% | $84.03M | |
| 12.10% | $82.83M | |
| 6.91% | $85.77M | |
| -135.04% | $4.28M | |
| 0% | $82.40M | |
| -0.02% | $87.43M | |
| -0.12% | $86.22M | |
| -0.18% | $4.92M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like MedTech Acquisition Corporation using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like MedTech Acquisition Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is MedTech Acquisition Corporation's ROE?
How is the ROE calculated for MedTech Acquisition Corporation (MTACU)?
What is the highest ROE for MedTech Acquisition Corporation (MTACU)?
What is the 3-year average ROE for MedTech Acquisition Corporation (MTACU)?
What is the 5-year average ROE for MedTech Acquisition Corporation (MTACU)?
How does the current ROE for MedTech Acquisition Corporation (MTACU) compare to its historical average?